Promoter holding
64.27%
KP
Kredenz Pharma Private Limited - Due diligence report
A 360° intelligence report on Kredenz Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Kredenz Pharma Private Limited — 360° Intelligence Report
Generated from MCA filings & public records94/100
Trust Score
Low Risk
Kredenz Pharma Private Limited is assessed as Low Risk with a Trust Score of 94/100. Kredenz Pharma Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Kredenz Pharma Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
94/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 1 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 100/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MADHUKAR VEMPALLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PARTHASARATHY RAJAGOPALAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JAGAN MOHAN REDDY NARSA REDDY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 90
Growth signals & trust indicators
Operating for 10+ years.
Distress signals & risk flags
No critical warning flags detected in the available data.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment95/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view55/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 6 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
25 May 2016
Incorporated
Registered with Roc Hyderabad
Director appointed
MADHUKAR VEMPALLA (Director)
Director appointed
PARTHASARATHY RAJAGOPALAN (Director)
Director appointed
JAGAN MOHAN REDDY NARSA REDDY (Director)
10
Key Observations
Auto-generated from the data aboveCompliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
| Company | CIN | Location |
|---|---|---|
| Techzuiver Enterprises Private Limited | U74140DL2015PTC283510 | New Delhi, Delhi, India |
| Savya Foods Private Limited | U51909RJ2017PTC056914 | Jaipur, Rajasthan, India |
| Carenyc Pharmaceuticals Private Limited | U74999DL2016PTC303031 | New Delhi, Delhi, India |
| Diya Suppliers Private Limited | U51909WB2011PTC156570 | Kolkata, West Bengal, India |
| Agronomics Agriculture And Farming India Private Limited | U01100WB1991PTC053012 | Kolkata, West Bengal, India |
| Omshaktidev Skyscrapers Private Limited | U70109WB2012PTC182019 | Kolkata, West Bengal, India |
| Jhunjhunwala Advisory Services Private Limited | U74999WB2010PTC152448 | Kolkata, West Bengal, India |
| Ohm Tradex Bullion Private Limited | U51900DL2012PTC236413 | Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Kredenz Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Kredenz Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Kredenz Pharma Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 94/100, distress signals and MSME payment-delay disclosures - know whether Kredenz Pharma Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Kredenz Pharma Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Kredenz Pharma Private Limited an active company?
Kredenz Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).
Is Kredenz Pharma Private Limited financially healthy?
Kredenz Pharma Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Kredenz Pharma Private Limited?
Its overall Trust Score is 94/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Kredenz Pharma Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Kredenz Pharma Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Kredenz Pharma Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).
Is it risky to lend to Kredenz Pharma Private Limited?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
